|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.60 CNY | -2.21% |
|
+4.96% | +14.42% |
| Jun. 24 | China Approves Pulike's Quadrivalent Newcastle Disease Vaccine for Chickens | MT |
| Jun. 12 | Pulike Biological Engineering Gets Nod for Chicken Vaccine's Registration | MT |
| Capitalization | 4.99B 695M 597M 556M 517M 954M 59.88B 1.07B 6.72B 2.53B 28.08B 2.61B 2.55B 103B | P/E ratio 2025 * |
28.4x | P/E ratio 2026 * | 23.7x |
|---|---|---|---|---|---|
| Enterprise value | 4.99B 695M 597M 556M 517M 954M 59.88B 1.07B 6.72B 2.53B 28.08B 2.61B 2.55B 103B | EV / Sales 2025 * |
3.97x | EV / Sales 2026 * | 3.56x |
| Free-Float |
52.03% | Yield 2025 * |
1.85% | Yield 2026 * | 2.4% |
More valuation ratios
* Estimated data
More news
| 1 day | -2.21% | ||
| 1 week | +4.96% | ||
| Current month | +7.27% | ||
| 1 month | +9.45% | ||
| 3 months | +15.87% | ||
| 6 months | +18.31% | ||
| Current year | +14.42% |
| 1 week | 13.99 |  | 15.08 |
| 1 month | 13.11 | | 15.08 |
| Current year | 11.28 | | 15.53 |
| 1 year | 10.8 | | 15.53 |
| 3 years | 10.8 | | 34.9 |
| 5 years | 10.8 | | 34.9 |
| 10 years | 10.58 | | 34.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Fei Hu
CEO | Chief Executive Officer | 52 | 2020-02-25 |
Lian Feng Pei
DFI | Director of Finance/CFO | 52 | 2011-03-22 |
Rui Zhao
SEC | Corporate Secretary | 41 | 2016-05-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Ke Zhang
CHM | Chairman | 62 | 2011-03-22 |
Fei Hu
BRD | Director/Board Member | 52 | 2011-03-22 |
Yong Jun Song
BRD | Director/Board Member | 57 | 2011-03-22 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.21% | +4.96% | +14.69% | -43.01% | 695M | ||
| -0.62% | -4.10% | -16.79% | -16.24% | 66.16B | ||
| -1.20% | -0.81% | +16.19% | -28.32% | 7.34B | ||
| +1.21% | +2.55% | -7.97% | +4.80% | 3.75B | ||
| -0.14% | +3.96% | +1.29% | -3.27% | 3.46B | ||
| -13.80% | -10.82% | +4.46% | -8.55% | 2.03B | ||
| -1.51% | +9.46% | +60.00% | +24.25% | 1.36B | ||
| -1.08% | -4.51% | +57.78% | +45.45% | 1.19B | ||
| -3.90% | +4.78% | +17.06% | -33.97% | 1.12B | ||
| -0.62% | +2.05% | -22.42% | -36.83% | 1.09B | ||
| Average | -2.39% | +0.40% | +12.43% | -9.57% | 8.82B | |
| Weighted average by Cap. | -0.95% | -2.95% | -9.67% | -14.90% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.26B 175M 150M 140M 130M 240M 15.07B 268M 1.69B 638M 7.07B 656M 643M 25.97B | 1.4B 195M 167M 156M 145M 268M 16.8B 299M 1.88B 711M 7.88B 732M 716M 28.95B |
| Net income | 177M 24.7M 21.2M 19.75M 18.37M 33.9M 2.13B 37.85M 239M 90.06M 998M 92.66M 90.75M 3.67B | 214M 29.77M 25.54M 23.8M 22.14M 40.85M 2.56B 45.61M 287M 109M 1.2B 112M 109M 4.42B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
1,551
Sector
Pharmaceuticals
Calendar
Aug. 28
- Q2 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-18 | 14.60 ¥ | -2.21% | 7,292,045 |
| 25-07-17 | 14.93 ¥ | +0.95% | 7,874,500 |
| 25-07-16 | 14.79 ¥ | +3.43% | 8,824,700 |
| 25-07-15 | 14.30 ¥ | +0.78% | 5,360,000 |
| 25-07-14 | 14.19 ¥ | +2.01% | 6,989,500 |
End-of-day quote Shanghai S.E., July 17, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
14.60CNY
Average target price
15.42CNY
Spread / Average Target
+5.59%
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603566 Stock
Select your edition
All financial news and data tailored to specific country editions
